CRELD1

Chr 3ADAR

CRELD disulfide isomerase 1

Also known as: AVSD2, CIRRIN, JELANS

This gene encodes a member of a subfamily of epidermal growth factor-related proteins. The encoded protein is characterized by a cysteine-rich with epidermal growth factor-like domain. This protein may function as a cell adhesion molecule. Mutations in this gene are the cause of atrioventricular septal defect. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]

OMIMResearchGenerating clinical summary…
MultiplemechanismAD/ARLOEUF 1.053 OMIM phenotypes
Clinical SummaryCRELD1
🧬
Gene-Disease Validity (ClinGen)
congenital heart disease · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
15 unique Pathogenic / Likely Pathogenic· 117 VUS of 241 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.05LOEUF
pLI 0.000
Z-score 1.36
OE 0.73 (0.521.05)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.17Z-score
OE missense 0.97 (0.871.08)
235 obs / 242.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.73 (0.521.05)
00.351.4
Missense OE?0.97 (0.871.08)
00.61.4
Synonymous OE?1.20
01.21.6
LoF obs/exp: 21 / 28.9Missense obs/exp: 235 / 242.7Syn Z: -1.48
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedCRELD1-related atrioventricular septal defect susceptibilityOTHERAD
moderateCRELD1-related neurodevelopmental disorder with hypotonia and seizuresOTHERAR

This gene — mechanism propensity

DN
0.6161th %ile
GOF
0.6344th %ile
LOF
0.3358th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

241 submitted variants in ClinVar

Classification Summary

Pathogenic11
Likely Pathogenic4
VUS117
Likely Benign55
Benign26
Conflicting10
11
Pathogenic
4
Likely Pathogenic
117
VUS
55
Likely Benign
26
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
7
4
0
0
11
Likely Pathogenic
4
0
0
0
4
VUS
9
101
6
1
117
Likely Benign
0
9
14
32
55
Benign
0
3
16
7
26
Conflicting
10
Total201173640223

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

48 pathogenic / likely-pathogenic (of 68) ClinVar copy-number / structural variants overlap CRELD1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CRELD1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.